Non-alcoholic fatty liver disease. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: All the volunteers who meet the entry criteria were directed to the laboratory and imaging center so that biochemical tests and liver fibroscans can be performed on them before taking
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 30 and 65 years Consistency of exercise program Body mass index less than 40 Not having a specific disease Not drinking alcohol
Exclusion criteria
Exclusion criteria: Performing CABG surgery, occurrence of ASC, heart and brain stroke, pulmonary embolism, deep vein thrombosis or TIA in the last 1 year Taking anti-inflammatory drugs such as aspirin with an anti-inflammatory dose, antioxidant supplements, vitamins and omega-3 capsules (<1 g/day), and immunosuppressive drugs in the last three months Presence of cancer, liver and thyroid diseases pregnancy alcohol consumption Taking drugs that lower blood cholesterol and triglycerides
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver steatosis level. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Fibroscan. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum levels of ALT. Timepoint: Before the intervention and 40 days after the intervention. Method of measurement: Biochemical Autoanalyzor. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Pourghadamyari
Kerman University of Medical Sciences
Outcome results
None listed